UCrest Berhad, an investment holding company, (0005) Fair Value & Analysis
Healthcare · MY · Market cap 44.6M MYR
Fair value as of: Jun 26, 2026
From 24 valuation models · updated 3 days ago
Fair value updated Jun 26, 2026 — revised from 0.1200 MYR to 0.1008 MYR (−16.0%) since Jun 25, 2026. Share price +8.3% over the past month.
Price vs Fair Value (12 months)
12‑month range 0.0550 MYR – 0.1000 MYR · fair‑value band 0.0748 MYR – 0.1203 MYR · the 0.0650 MYR price screens below the 0.1008 MYR fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
UCrest Berhad, an investment holding company, (0005) currently trades at 0.0650 MYR, while our model-based Fair Value estimate is 0.1008 MYR — implying the stock looks roughly 55.0% undervalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, UCrest Berhad, an investment holding company, generated revenue of 14.0M MYR at a net margin of 15.1%. Revenue declined 44.8% year over year. It earns a return on equity of 4.9%. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
UCrest Berhad, an investment holding company, engages in the design, development, and marketing of information technology related products and services in Malaysia and Singapore. The company offers iMedic cloud hospital that is used by doctors and patients for the diagnosis, management, and treatment of chronic diseases, such as cardiovascular diseases (CVD), cancer, diabetes, hypertension, sleep apnea, stroke rehabilitation, and other diseases in the United States, China, Singapore, Malaysia, Taiwan, Indonesia, Vietnam, and the Middle East. It also provides mobile healthcare services. The company was formerly known as Palette Multimedia Berhad and changed its name to UCrest Berhad in November 2017. UCrest Berhad was incorporated in 1997 and is based in Petaling Jaya, Malaysia.
Revenue & earnings trend
FY2020 – FY2024 · reported fiscal years
UCrest Berhad, an investment holding company, reported revenue of 18.1M MYR in FY2024 versus 25.5M MYR in FY2020, a compound −8.2%/yr. Reported net income was 4.7M MYR in FY2024, compounding −20.0%/yr from FY2020.
Open the full interactive analysis →
Similar stocks
6 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $163.76 | $103.58 | -37% |
| Pro Medicus Limited PME | A$172.80 | A$32.25 | -81% |
| BrightSpring Health Services, Inc BTSG | $57.40 | $23.87 | -58% |
| Tempus AI, Inc TEM | $48.61 | $12.67 | -74% |
| HealthEquity, Inc HQY | $89.72 | $54.47 | -39% |
| M3, Inc MTHRY | $5.03 | $7.44 | +48% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is UCrest Berhad, an investment holding company, (0005) undervalued?
What is the fair value of 0005?
What is the quality score of 0005?
What is the revenue of UCrest Berhad, an investment holding company, (0005)?
What is the net profit margin of 0005?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.